Genes in MS Patients Nyack NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

L Alburquerque
(973) 684-1302
412 Park Ave
Paterson, NJ
Carolina Ma Takizawa
(718) 918-5000
1400 Pelham Pkwy S
Bronx, NY
Stacey Maddoff
(914) 666-5125
666 Lexington Ave # 200
Mount Kisco, NY
John Mastrantonio
(914) 961-0201
1925 Central Park Ave
Yonkers, NY
Karina Zhuravleva
201-943-4884
434 Palisade Avenue
Cliffside Park, NJ
Katayoun Meyer
(203) 861-0911
100 Melrose Ave Ste 202
Greenwich, CT
Ann Deangelo
(201) 385-7300
55 W Main St
Bergenfield, NJ
David H Barad
(914) 693-8820
20 Beacon Hill Dr
Dobbs Ferry, NY
J Motola
(914) 739-1219
666 Lexington Ave # 210
Mount Kisco, NY
Grace Ilanjian
(914) 337-3960
226 White Plains Road
Eastchester, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Nyack NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- Gene Variants and Alzheimer's Risk Nyack NY
- Side Effect Of Chemotherapy Drugs Nyack NY
- Hospice: Getting Back Control of Your Life Nyack NY
- Doctor-Patient Talk for Hypertension Nyack NY
- High Blood Pressure Genes Nyack NY
- Gene Therapy for Parkinson's Nyack NY
- Depression in Heart Disease Patients Nyack NY
- Exercise for Chemotherapy Patients Nyack NY
- Differences Between Hospice and Palliative Care Nyack NY